Bevac Vaccine is an active immunizing agent used to provide protection against hepatitis B virus (HBV) infection. Hepatitis B is a potentially serious liver infection caused by HBV, which can lead to chronic liver disease, liver failure, or even liver cancer. The Bevac Vaccine helps the body develop immunity by stimulating the immune system to produce antibodies against the virus, without causing the disease itself.
This vaccine is especially recommended for individuals at a higher risk of HBV exposure, such as healthcare workers, people with multiple sexual partners, patients undergoing dialysis, or those living in areas with a high prevalence of hepatitis B. It is also included in the routine immunization schedule for infants and children in many countries.
Bevac Vaccine is usually administered as an intramuscular injection, typically in a series of three doses over a six-month period for full protection. It is important to complete the full course as recommended by a healthcare provider.
The vaccine is generally well tolerated. Mild side effects may include pain at the injection site, fever, or fatigue. Serious side effects are rare. Bevac Vaccine plays a critical role in the prevention of hepatitis B and helps reduce the long-term burden of liver disease in at-risk populations.
Reviews
There are no reviews yet.